Skip to content

Feasibility of the Hip Instructional Prehabilitation Program for Enhanced Recovery (HIPPER)

Feasibility of the Hip Instructional Prehabilitation Program for Enhanced Recovery (HIPPER) Intervention Protocol: An eHealth Approach for Pre-surgical Hip Replacement Education

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02969512
Acronym
HIPPER
Enrollment
51
Registered
2016-11-21
Start date
2021-01-10
Completion date
2023-04-25
Last updated
2026-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Osteoarthritis

Keywords

Patient education, Advanced hip osteoarthritis, Online education, Computer-assisted instruction, e-learning, Older adult

Brief summary

Osteoarthritis (OA), leading to hip replacement, is a leading contributor to global mobility impairment. Given the boom in the older demographic it is not surprising that there is an 11% increased demand for replacement every 5 years in Canada. Health promotion interventions, such as prehabilitation, defined as pre-surgical education, are vital to optimizing surgical outcomes, reducing hospitalization costs, accelerating rehabilitation, and reducing patient discomfort and pre-operative anxiety. HIPPER is a 2-year randomized controlled trial (RCT) that will assess feasibility indicators and clinical outcomes of online prehab education modules compared to online educational webinars. The feasibility indicators (process, resource, management, and treatment issues) and clinical outcomes (physical function, anxiety, depression, pain, daily activities, self-efficacy, and health related quality of life) will be assessed among Vancouver-dwelling older adults aged \> 50 years, with advanced hip osteoarthritis. The findings will lead to the refinement of the design protocol in order to evaluate a contemporary, standardized, and geographically accessible prehab education program in a large multi-site RCT.

Detailed description

This feasibility study will use a single-site, parallel group evaluator blind RCT. Subjects (N=40) will be randomly assigned to the experimental (HIPPER n=20) or control (n=20) groups.The experimental group will receive the interactive online HIPPER intervention consisting of 12 modules (\ 20 mins/module). The control group is usual practice consisting of a 2 hr online large group educational webinar. Feasibility indicators (i.e. recruitment and retention; subject burden; safety; intervention administration/adherence; perceived benefit) will be evaluated as binary outcomes against pre-set parameters reflecting viability for a multi-site large-scale RCT. The primary clinical outcome of interest when assessing effect size for the eventual RCT is the Hospital Anxiety and Depression Scale-Anxiety. Secondary clinical outcomes include measures of pain, function, daily activities, self-efficacy, equipment checklist, system usability scale, environmental setup, physical activity, and health related quality of life. Upon successful screening/enrollment and baseline data collection (T1) the Study Coordinator will contact the statistician by telephone or email and obtain group assignment within 48 hours. Subjects will be randomized using a 1:1 allocation ratio between groups. A central computerized randomization process will be designed by the statistician, with an undisclosed block size. To address bias, subjects will be instructed not to discuss their program and Testers will reinforce this point at each session. T1 data will be collected at our clinic while the follow up data collected 7-10 days prior to surgery (T2), and 30 days post-surgery (T3). The findings from the study will be summarized and mailed to each participant upon study completion. HIPPER and control group assessments will be held at GF Strong Rehabilitation Centre and at subject's homes. The outcome will lead to the refinement of the design protocol in order to robustly evaluate a contemporary, standardized, and geographically accessible prehabilitation education program. Ultimately, HIPPER may be found to have significant individual and social (health system level) benefits.

Interventions

OTHERHIPPER

Participants can complete the online educational modules at home or another location with internet access. The total time to complete all of the modules is about 2 hours and 30 minutes.

OTHEROASIS Online Educational Webinars

2-hour online educational large group sessions

Sponsors

University of British Columbia
Lead SponsorOTHER
Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Community-dwelling participants with advanced hip OA will be included if they: * are living in the greater Vancouver region; * are aged 50 years or older; * are scheduled to have a single THR in 12 weeks or later; * have access to the internet

Exclusion criteria

* cannot communicate and complete questionnaires in English; * anticipate a health condition or procedure that contraindicates their THR surgery; * are actively receiving physical therapy for their hip symptoms; * have had a previous THR.

Design outcomes

Primary

MeasureTime frameDescription
Hospital Anxiety and Depression Scale - Anxiety Subscale (HADS-A)T1 (Baseline); T2 (7-10 days before surgery); T3 (Post-Intervention, 30 days after surgery)The Hospital Anxiety and Depression Scale (HADS-A) measures anxiety symptoms. The anxiety subscale (HADS-A) has 7 items, each rated 0-3 and summed to a total of 0-21. Higher scores indicate worse outcomes (greater anxiety).

Secondary

MeasureTime frameDescription
Hip Disability and Osteoarthritis Outcome Score - Activities of Daily Living Subscale (HOOS-ADL)T1 (Baseline); T2 (7-10 days before surgery); T3 (Post-Intervention, 30 days after surgery)The Hip Disability and Osteoarthritis Outcome Score (HOOS) Activities of Daily Living (ADL) subscale measures difficulty with daily activities in patients with hip osteoarthritis. It has 17 items, each rated on a five-point Likert scale (0 = none to 4 = extreme difficulty), summed to a total ranging from 0 to 68. Higher scores indicate greater difficulty with daily activities.
Physical Activity Scale for the Elderly (PASE)T1 (Baseline); T2 (7-10 days before surgery); T3 (Post-Intervention, 30 days after surgery)The Physical Activity Scale for the Elderly (PASE) measures self-reported physical activity over the past 7 days in older adults. Scores are a weighted sum of time spent across activity types, ranging from 0 to 400 or more. Higher scores indicate greater physical activity.
EuroQol 5-Dimension 5-Level (EQ-5D-5L) Index ScoreT1 (Baseline); T2 (7-10 days before surgery); T3 (Post-Intervention, 30 days after surgery)The EuroQol 5-Dimension 5-Level (EQ-5D-5L) measures health-related quality of life across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Responses were converted to a single utility index ranging from -0.285 to 1 (extreme problems on all dimensions) to 1 (full health). Higher scores indicate better health-related quality of life.
Equipment ChecklistT1 (Baseline); T2 (7-10 days before surgery); T3 (Post-Intervention, 30 days after surgery)The Equipment Checklist included recommended equipment and mobility aids for total hip replacement. This checklist was developed in accordance with current guidelines and clinical recommendations. Participants indicated which items they had obtained. The reported value is the number of items obtained per participant. Higher scores indicate more recommended equipment obtained.
30-second Chair-Stand TestT1 (Baseline); T2 (7-10 days before surgery).The 30-Second Chair-Stand Test measures lower-body strength and endurance. Participants stand fully from a seated position and sit back down as many times as possible within 30 seconds. The score is the number of completed sit-to-stand repetitions. Higher scores indicate better lower-body strength and function.
Hospital Anxiety and Depression Scale - Depression Subscale (HADS-D)T1 (Baseline); T2 (7-10 days before surgery); T3 (Post-Intervention, 30 days after surgery)The Hospital Anxiety and Depression Scale (HADS-D) measures depression symptoms. The depression subscale (HADS-D) has 7 items, each rated 0-3 and summed to a total of 0-21. Higher scores indicate higher levels of depression.
Oxford Hip Score (OHS)T1 (Baseline); T2 (7-10 days before surgery); T3 (Post-Intervention, 30 days after surgery)The Oxford Hip Score (OHS) measures pain and function in patients with hip osteoarthritis. It has 12 items, each rated 0-4, summed to a total of 0-48. Higher scores indicate lower levels of disability.
System Usability Scale (SUS)T2 (7-10 days before surgery); T3 (Post-Intervention, 30 days after surgery); Completed only by participants in the HIPPER group.The System Usability Scale (SUS) measures perceived usability of a system. It has 10 items rated on a 5-point scale; item scores are converted, summed, and multiplied by 2.5 to give a total of 0-100. Higher scores indicate better perceived usability.
Change in Self-Efficacy for Rehabilitation Outcome Scale (SER)T1 (Baseline); T2 (7-10 days before surgery); T3 (Post-Intervention, 30 days after surgery)The Self-Efficacy for Rehabilitation Outcome Scale (SER) measures confidence in performing rehabilitation activities. It has 12 items, each rated 0-10, summed to a total of 0-120. Higher scores indicate greater self-efficacy.

Countries

Canada

Contacts

PRINCIPAL_INVESTIGATORWilliam C Miller, PhD

University of British Columbia

Baseline characteristics

Characteristic
Age, Continuous65.88 Years
STANDARD_DEVIATION 9.15
Birthplace
Canada
19 Participants
Birthplace
Other
7 Participants
Education Level
Completed higher education
16 Participants
Education Level
Completed high school
9 Participants
Education Level
Some High School
0 Participants
Employment Status
Employed
12 Participants
Employment Status
on disability
3 Participants
Employment Status
Other
1 Participants
Employment Status
Retired
20 Participants
Gender
Man
12 Participants
Gender
woman
15 Participants
General Health Status (self-reported)
Excellent
6 Participants
General Health Status (self-reported)
Fair
2 Participants
General Health Status (self-reported)
Good
9 Participants
General Health Status (self-reported)
Poor
1 Participants
General Health Status (self-reported)
Very good
14 Participants
Gross Annual Household Income
$14,999 or less
1 Participants
Gross Annual Household Income
$15,000 to $44,999
5 Participants
Gross Annual Household Income
$45,000 to $74,999
8 Participants
Gross Annual Household Income
$75,000 or more
11 Participants
Gross Annual Household Income
Prefer not to say
2 Participants
Height169.78 cm
STANDARD_DEVIATION 8.12
Living situation
Live alone
6 Participants
Living situation
Live with 2+ family member
3 Participants
Living situation
Live with healthy spouse/partner
14 Participants
Living situation
Live with spouse/partner I care for
1 Participants
Living situation
Other
2 Participants
Other Medical Conditions
Anxiety
4 Participants
Other Medical Conditions
Chronic/Long-term pain
9 Participants
Other Medical Conditions
Depression
1 Participants
Other Medical Conditions
Diabetes
1 Participants
Other Medical Conditions
High Blood pressure
7 Participants
Other Medical Conditions
Lower Back pain
8 Participants
Other Medical Conditions
Lung Disease
0 Participants
Other Medical Conditions
Other
9 Participants
Other Medical Conditions
Other hip, knee, or lower limp pain problems
10 Participants
Other Medical Conditions
Overweight or obese
9 Participants
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
15 Participants
Sex: Female, Male
Male
11 Participants
Weight77.17 KG
STANDARD_DEVIATION 11.94

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 261 / 25
other
Total, other adverse events
0 / 260 / 25
serious
Total, serious adverse events
0 / 261 / 25

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 18, 2026